Τόμος 1 (1987) – Τεύχος 1 – Άρθρο 4 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 1 (1987) – Issue 1 – Article 4 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title The receptor for glucocorticoid hormones: an insight into its structure and cellular dynamics
Authors M.N. Alexis, I. Mavridou, L. Baki and C. KioussiBiological Research Center, The National Hellenic Research Foundation
Citation Alexis, M.N., Mavridou, I., Baki L. and Kioussi, C.: The Receptor for Glucocorticoid Hormones: an insight into its structure and cellular dynamics, Epitheorese Klin. Farmakol. Farmakokinet. 1(1): 39-54 (1987)
Publication Date 1987-07
Full Text Language English
Order – Buy Ηλεκτρονική Μορφή: pdf (10 €)Digital Type: pdf (10 €)pharmakonpress[at]pharmakonpress[.]gr
Keywords Receptor, glucocorticoid, hormone, structure, function in vivo.
Other Terms review article
Summary Glucocorticoid hormone receptor (GR) is a regulatory factor of eukaryotic gene transcription acting by hormone receptor complex, binding to transcriptional enhancer (DNA) elements in vivo. The response is elicited by hormone-induced conformational ‘transformation’ and ‘translocation’ of the hormone-GR complex from the cytoplasm to the nucleus. The role of the receptor in eliciting the glucocorticoid response is investigated with Dexamethasone 21-mesylate (DM), which covalently links the synthetic glucocorticoid Dexamethasone (Dex) to the receptor. The purification of the non-transformed and the transformed form of the GR by affinity chromatography and ion-exchange chromatography respectively led to the production of specific antibodies in rabbits. The use of immunochemical methods and receptor labeling techniques for analysing the fine structure and subunit constitution of the receptor in the non-transformed and transformed conformation is described. Examination of GR fine structure revealed several proteolytic ‘hinge’ regions likely involved in receptor transformation and turnover in vivo. Differential sensitivity of some of the ‘hinges’ to the presence of calcium ions is established, suggesting a signaling mechanism sensitive to several other hormones and growth factors. Evidence is presented on a putative subunit constitution of the non-transformed form suggesting that it is a heteropolymer comprising at least one non-steroid binding subunit in addition to the GR. These data on the GR structure are discussed with respect to receptor cellular dynamics and function in vivo.
References 1.         Karlson, P., Sekeris, C.E.: Biochemical mechanism of hormone action. Acta Endocrin. 53: 505 (1966)2.         Giguere, V., Hollenberg, S.M., Rosenfeld, M.G., Evans. R.M.: Functional domains of the human glucocorticoid receptor. Cell 46: 645 (1986)

3.         Green, S., Chambon, P.: A superfamily of potentially oncogenic hormone receptors. Nature 324: 615 (1986)

4.         Tsawdaroglou, N.G., Govindan, M.V., Schmid, W., Sekeris, C.E.: Dexamethasone-binding proteins in cytosol and nucleus of rat thymocytes. Purification of three receptor proteins. Eur. J. Biochem. 114: 305 (1981)

5.         Grandics, P., Puri, R.K., Toft, D.O.: A new affinity resin for purification of non-transformed avian progesterone receptor. Endocrinology 110: 1055 (1982)

6.         Atache, V., Ratajczak, T., Senafi, S., Hahnel, R.: Purification of the molybdate-stabilized 9-10 S estradiol receptor from calf uterus. J. Biol. Chem. 260: 5936 (1985)

7.         Grovindan, M.V., Sekeris, C.E.: Purification of two dexamethasone-binding proteins from rat liver cytosol. Eur. J. Biochem. 89: 95 (1978)

8.         Manz, B., Heubner, A., Kohler, I., Grill, H.J., Pollow, Κ.: Synthesis of biotin-labelled dexamethasone derivatives. Novel hormone affinity probes. Eur. J. Biochem. 131: 333 (1983)

9.         Westphall, H.M., Beato, M.: The activated glucocorticoid receptor of rat liver purification and physical characterization. Eur. J. Biochem. 106: 395 (1980)

10.       Govindan, M.V., Manz, B.: Three-step purification of glucocorticoid receptors from rat liver. Eur. J. Biochem. 108: 47 (1980)

11.       Eisen, H.J., Schleenbaker, R.E., Simons, S.S. Jr.: Affinity labelling of the rat liver glucocorticoid receptor with dexamethasone 21<-mesylate. Identification of covalently labelled receptor by immunochemical methods. J. Biol. Chem. 256: 12920 (1981)

12.       Lustenberger, P., Formstecher, P., Dautrevaux, M.: Purification of rat liver glucocorticoid receptor by affinity chromatography: desing of a suitable adsorbent. J. Steroid. Biochem. 14: 697 (1981)

13.       Carlstedt-Duke, J., Ok ret. S., Wrange, 0-, Gustafsson, J.A.: Immunochemical analysis of the glucocorticoid receptor: identification of a third domain separate from the steroid-binding and DNA-binding and DNA-binding domains. Proc. Nat. Acad. Set. 79: 4260 (1982)

14.       Markovic, R.D., Eisen, H.J., Parchman, L.G., Barnett, C.A., Litwack, G.: Evidence for a physiological role of corticosteroid binder IB. Biochemistry 1b: 4556 (1980)

15.       Mayer, M„ Schmidt, T.J., Barnett, C.A., Miller, A., Litwack, G.: In vitro production of corticosteroid binder IB in the presence of proteolytic inhibitors. J. Steroid. Biochem. 18: 111 (1983)

16.       Eisen, L.P., Harrison, R.W., Harmon, J.M.: Immunochemical characterization of the rat kidney glucocorticoid receptor. The role of proteolysis in the formation of corticosteroid binder IB. J. Biol. Chem. 261: 3725 (1986)

17.       Webb, M.L., Miller-Diener, A.S., Litwack, G.: Purification, characterization and activation of the glucocorticoid-receptor complex from rat kidney cortex. Biochemistry 24: 1946 (1985)

18.       Govindjn, M.V., Gronemeyer, H.: Characterization of the rat liver glucocorticoid receptor purified by DNA-cellulose and ligand affinity chromatography. J. Biol. Chem. 259: 12915 (1984)

19.       Grandics, P., Miller, A., Schmidt, T.J., Mittman, D., Litwack, G.: Purification of the unactivated glucocorticoid receptor and its subsequent in vitro activation. J. Biol. Chem. 259: 3173 (1984)

20.       Idziore, K.T., Formstecher, P., Oanze, P.-M., Salbonniere, B., Lustenberger, P., Richard, C., Dumur, V., Dautrevaux, M.: Characterization of the purified molybdate-stabilized glucocorticoid receptor from rat liver. An in vitro transformable complex. Eur. J. Biochem. 153: 65 (1985)

21.       Wrange, 0., Carlstedt-Duke, J., Gustafsson, J.A.: Purification of the glucocorticoid receptor from rat liver cytosol. J. Biol. Chem. 254: 9284 (1979)

22.       Eisen, H.J., Glinsmann, W.H.: Maximizing the purification of the activated glucocorticoid receptor by DNA- cellulose chromatography. Biochem. J. 171: 177 (1978)

23.       Wrange, O., Okret, S., Radojiifc, M., Carlstedt-Duke, J., Gustafsson, J.-A.: Characterization of the purified activa-ted glucocorticoid receptor from rat liver cytosol. J. Biol. Chem. 259: 4534 (1984)

24.       Vaitukaitis, J., Robbins, J.B., Nieschlag, E., Ross, G.T.: A method for producing specific antisera with small doses of immunogen. J. Clin. Endocr. 33: 988 (1971)

25.       Becker, P.B., Gloss, Bv Schmid, W., Strahle, U., SchCitz, G.: In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone. Nature 324: 686 (1986)

26.       Willmann, T„ Beato, M.: Steroid-free glucocorticoid receptor binds specifically to mouse mammary tumour virus DNA. Nature 324: 688 (1986)

27.       Wrange, O., Gustafsson, J.A.: Separation of the hormone- and DNA-binding sites of the hepatic glucocorticoid receptor by means of proteolysis. J. Biol. Chem. 253: 856 (1978)

28.       Weinberger, C., Hollenberg, S.M., Rosenfeld, M.G., E- vans, R.M.: Domain structure of human glucocorticoid receptor and its relationship to the verb-A oncogene product. Nature 318: 670 (1985)

29.       Reichman, M.E., Foster, C.M., Eisen, L.P., Eisen, H.J., Torain, B.F., Simons, S.S.; Limited proteolysis of covalently labeled glucocorticoid receptors as a probe of receptor Structure. Biochemistry 23: 5376 (1984)

30.       Puca, G.A., Abbondanza, C., Nigro, V., Armetta, I., Medici, N., Molinari, A.M.: Estradiol receptor has proteolytic activity that is responsible for its own transformation. Proc. Natl. Acad. Sci. (USA) 83: 5367 (1986)

31.       Dahmer, M.K., Tienrungroj, W„ Pratt, W.B.: Purification and preliminary characterization of a macro molecular inhibitor of glucocorticoid receptor binding to DNA. J. Biol. Chem. 260: 7705 (1985)

32.       Bodwell, J.E., Holbrook, N.J., Munck, A.: Stabilization of thymic glucocorticoid-receptor complexes by the calcium-activated protease inhibitor, calpastatin. J. Biol. Chem.260: 2601 (1985)

33.       McIntyre, W.R., Samuels, H.H.: Triamcinolone acetonide regulates glucocorticoid-receptor levels by decreasing the half-life of the activated nuclear-receptor forms. J. Biol. Chem. 260: 418 (1985)

34.       Luttge, W.G., Gray, H.E., Densmore, C.L.: Hydrodynamic and biochemical correlates of the activation of the glucocorticoid-receptor complex. J. Steroid. Biochem. 20: 545 (1984)

35.       Scheidereit, C., Kranter, P., von der Ahe, D., Janich, S., Rabenan, 0., Cato, A.C.B., Suske, G., Westphal, H.N., Beato, M.: Mechanism of gene regulation by steroid hormones. J. Steroid. Biochem. 24: 19 {1986)

36.       Mendel, D.B., Bodwell, J.E., Gametchu, B., Harrison, R.W., Munck, A.: Molybdate-stabilized nonactivated glucocorticoid-receptor complexes contain a 90 KDa non-steroid-binding phosphoprotein that is lost on an activation. J. Biol. Chem. 261: 3758 (1986)

37.       Sanchez, E.R., Housley, P.R., Pratt, W.B.: The molybdate-stabilized glucocorticoid binding complex L-cells contains a 98-100 KDa steroid binding phosphoprotein and a 90 KDa nonsteroid-binding phosphoprotein that is part of the murine heat-shock complex. J. Steroid. Biochem. 24: 9 (1986)

38.       Tai, P.-K.K., Maeda, Y„ Nakao, K., Wakim, N.G., Duh- ring, J.L., Faber, L.E.: A 59 kilodalton protein associated with progestin, estrogen, androgen and glucocorticoid receptors. Biochemistry 25: 5269 (1986)

39.       Hansen, J.C., Gorski, J.: Conformational transitions of the estrogen receptor monomer. Effects of estrogen, antiestrogen and temperature. J. Biol. Chem. 261:13990 {1986)

40.       Alexis, M.N., Djordevid-Markovid, R., Sekeris, C.E.; Activation and changes in the sedimentation properties of rat liver glucocorticoid receptor. J. Steroid. Biochem. 18: 655 (1983)

41.       Ziemiecki, A., Cattelli, M.-G., Joab, I., Moncharmont, B.: Association of the heat shock protein HSP90 with steroid hormone receptors and tyrosine kinase oncogene products. Biochem. Biophys. Res. Commun. 138: 1298 (1986)

42.       Catelli, M.G., Binart, N., Jung-Testas, I., Renoir, J.M., Banlieu, E.E., Feramisco, J.R., Welch, W.J.: The common 90 kd protein component of nontransformed ‘8S’ steroid receptors is a heat-shock protein. EMBO J. 4: 3131 (1985)

43.       Nielsen, C.J., Sando, J.J., Vogel, W.M., Pratt, W.B.: Glucocorticoid receptor inactivation under cell-free conditions. J. Biol. Chem. 252: 7568 (1977)

44.       Housley, P.R., Dahmer, M.K., Pratt, W.B.: Inactivation of glucocorticoid-binding capacity by protein phosphatases in the presence of molybdate and complete reactivation by dithiothreitol. J. Biol. Chem. 257: 8615 (1982)

45.       Miller-Diener, A., Schmidt, T.J., Litwack, G.: Protein kinase activity associated with the purified rat hepatic glucocorticoid receptor. Proc. Natl. Acad. Sci. (USA) 82: 4003 (1985)

46.       Sanchez, E.R., Prat, W.B.: Phosphorylation of L-cell glucocorticoid receptor in immune complexes: evidence that the receptor is not a protein kinase. Biochemistry 25: 1378 (1986)

47.       Housiey, P.R., Pratt, W.B.: Direct demonstration of glucocorticoid receptor phosphorylation by intact L-cells. J. Biol. Chem. 258: 4630 (1983)

48.       Grandics, P., Miller, A., Schmidt, T.J., Litwack, G.: Phosphorylation in vivo of rat hepatic glucocorticoid receptor Biochem. Biophys. Res. Commun. 120: 59 (1984)

49.       Sinyh, V.B., Moudgil, V.K.: Phosphorylation of rat liver glucocorticoid receptor. J. Biol. Chem. 260: 3684 (1985)

50.       Goneli, S.A., Holtzman, J.L., Ahmed, Κ.: Phosphorylation of the androgen receptor by a nuclear cAMP-independent protein kinase. Biochem. Biophys. Res. Commun. 123: 778 (1984)

51.       Baldi, A., Boyle, D.M., Wittlift, J.L.: Estrogen receptor is associated with protein and phospholipid kinase activities. Biochem. Biophys. Res. Commun. 135: 597 (1986)

52.       Garcia, T., Buchon, T., Renoir, J.-M., Meter, J., Sanliem, E.-E.: A protein kinase copurified with chick oviduct progesterone receptor. Biochemistry 25: 7937 (1986)

53.       Logeat, F., LeCunff, M., Pamphiie, R., Milgrom, E.: The nuclear bound form of the progesterone receptor is generated through a hormone-dependent phosphorylation. Biochem. Biophys. Res. Commun. 131: 421 (1985)

54.       Woo, D.D.L., Fay, S.P., Griest, R., Coty, W., Goldfine, I., Fox, C.F.: Differential phosphorylation of the progesterone receptor by insulin, epidermal growth factor, and plateled-derived growth factor receptor tyrosine protein kinases. J. Biol. Chem. 261: 460 (1986)

55.       Munck, A.: Glucocorticoid receptor phosphorylation and cycles in lymphoid cells. VII International Congress on Hormonal Steroids – Madrid, Spain, 1986

56.       Garcia, T., Jung-Testsas, L., Baulieu, E.E.: Tightly bound nuclear progesterone receptor is not phosphorylated in primary chick oviduct cut lures. Proc. Natl. Acad. Sci. USA) 83: 7573 (1986)

57.       Mendel, D.B., Bodwell, J.E., Munck, A.: Glucocorticoid receptors lacking hormone-binding activity are bound in nuclei of ATP-depleted cells. Nature 324: 478 (1986)

58.       Gruol, D.J., Campbell, N.F., Bourgeois, S.: Cyclic AMP- dependent protein kinase promotes glucocorticoid receptor function. J. Biol. Chem. 261: 4909 (1986)

59.       Nardulli, A.M., Katzenellenbogen, B.S.: Dynamics of estrogen receptor turnover in uterine cell in vitro and in uteri in vivo. Endocrinology 119: 2038 (1986)

60.       Okret, S., Poellinger, L., Dong, Ye., Gustafsson, J.-A.: Down-regulation of glucocorticoid receptor mRNA by glucocorticoid hormones and recognition by the receptor of a specific binding sequence within a receptor cDNA clone. Proc. Natl. Acad. Sci. (USA) 83: 5899 (1986)

61.       Schuh, S., Yonemoto, W., Brugge, J., Bauer, V.J., Riehl, R.M., Sullivan, W.P., Toft, D.O.: A 90,000-dalton binding protein common to both steroid receptors and the rous sarcoma virus transforming protein pp60v-Sf J. Biol. Chem. 260: 14292 (1985)

62.       Wolffe, A.P., Pertmann, A.J., Teta, J.R.: Transient paralysis by heat shock of hormonal regulation of gene expression. EMBO J. 3: 2763 (1984).

 Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς –
What is Epitheorese Klinikes Farmakologias
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση –
Articles Published in Epitheorese Klinikes Farmakologias
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 1987 – ANNUAL SUBSCRIPTION 1987
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)pharmakonpress[at]pharmakonpress[.]gr
Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)pharmakonpress[at]pharmakonpress[.]gr

 

 

Bookmark the permalink.

Comments are closed.